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A previous study of 4 patients defined Andersen's syndrome (AS) as a triad of potassium-sensitive periodic paralysis, 
ventricular dysrhythmias, and dysmorphic features. AS appears to be distinct in terms of its genetic defect from the 
a-subunit of skeletal muscle sodium channel and the cardiac potassium channel responsible for most long QT syndromes 
(LQT1). We studied 11 additional patients with AS from 5 kindreds. Spontaneous attacks of paralysis were associated 
with hypokalemia, normokalemia, or hyperkalemia. All 11 patients had similar dysmorphic features. The QT interval 
was prolonged in all patients although only 4 were symptomatic. Genetic linkage studies excluded linkage to the 
a-subunit of the skeletal muscle sodium channel and to four distinct LQT loci. In addition, none of the common 
dihydropyridine receptor mutations responsible for hypokalemic periodic paralysis were present. We conclude that (1) 
AS is a genetically unique channelopathy affecting both cardiac and skeletal membrane excitability, (2) attacks of pa- 
ralysis may be either hypokalemic or hyperkalemic, (3) a prolonged QT interval is an integral feature of this syndrome, 
and (4) a prolonged QT interval may be the only sign in an individual from an otherwise typical AS kindred. This may 
be confused with more common, potentially lethal LQT syndromes. 
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Klein and co-workers [ I ]  were the first to emphasize 
that in  some forms of periodic paralysis [2, 31, cardiac 
dysrhythmias are a primary manifestation of the dis- 
ease, independent of serum potassium levels (Table 1) 
[ l ,  4-12]. Of the reported cases of periodic paralysis 
with cardiac involvement, a distinct syndrome has 
emerged consisting of a triad of episodic weakness, 
ventricular arrhythmias, and distinctive facial features 
[4, 10, 131. First described by Andersen, we named 
this condition Andersen's syndrome (AS) i n  a report of 
4 patients [13]. 
I n  three previously reported kindreds, periodic paral- 
psis was associated with hyperkalemia, bu t  genetic link- 
age to the skeletal muscle sodium channel was excluded 
[14-161. Because QT, intervals were prolonged i n  
three of four of the reported cases, we screened for and  
excluded linkage to the long QT syndrome locus on 
chromosome 11 (LQT1) [17, 181. 
We report on 11 additional patients with Andersen's 
syndrome, describing the distinctive physical features, 
associated cardiac abnormalities, and the relationship of 
serum potassium level to the episodic paralysis. In  ad- 
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dition, we performed linkage studies to the sodium 
channel gene [ 14-16] (hyperkalemic periodic paralysis; 
HyperKPP) and  four LQT loci [17, 181. Mutational 
analysis was performed on the dihydropyridine recep- 
tor  gene [ 191 (hypokalemic periodic paralysis, Hypo- 
KPP) . 
Patients and Methods 
We studied 11 patients from 5 kindreds by ncurological ex- 
amination and electrocardiography (ECG). The index cases 
had the following: (1) an electromyography (EMG), to assess 
rnyotonia according to previously described protocols, in- 
cluding the exercise test [20]; (2) a muscle biopsy; (3) hy- 
pokalemic and hyperkalemic challenges according to stan- 
dard protocols [2] ;  and (4) 24-hour Holter monitoring. '"he 
diagnosis of LQT syndrome was made according to standard 
criteria j21, 221. 
For genetic studies [ 131 in 2 three-generation kindreds we 
used markers tightly linked to the HyperKIT gene [14-161 
and four I.QT syndrome loci (LQ7'1-4) [17, 18, 211. Kin- 
dreds were not large enough to perform linkage analysis to 
the calcium channel gene, but mutational analysis was per- 
formed for possible mutations as previously described [ 191. 
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Table I .  Periodic Para1yziJ with Cardiac Involvement 
Study Periodic Paralysis Cardiac Arrhythmias Dysmorphisms 
Klein et a1 [I]  Spont [K+]: 3.7 Supraventricular and ventricular Not mentioned 
__ 
(1963; sporadic and autosomal dominant) Kt challenge: normal tachycardias 
glc challenge: not done 
Interattack NE: normal 
Lisak et a1 [4] 
(1970; autosomal dominant) 
Andersen et a1 [5] 
(1 971 ; sporadic) 
Levitt et a1 [GI 
(1 972; sporadic) 
Stubbs [7] 
(1976; autosonial dominant) 
Kramer et a1 [8] 
(1979); autosomal dominant) 
Yoshimura et a1 [9] 
(1 983; sporadic) 
Gould et a1 [lo] 
(1985; autosornal dominant) 
Fukuda et a1 [11] 
(1988; autosomal dominant) 
Baquero et a1 [12] 
(1995; sporadic) 
Spont [K+]: 4.5 
K+ challenge: weakness 
glc challenge: normal 
Interattack myopathy 
Spont [K+]: 4.7 
Kt challenge: not done 
glc challenge: weakness 
Interattack NE: 1 DTR 
Sptont [K+]: 2.8 
K challenge: not done 
glc challenge: weakness 
Interattack NE: 1 DTR 
Spont [K+]: 3.1 
K+ challenge: not done 
glc challenge: not done 
Interattack NE: normal 
Spont [K+]: 1.5 
Kt challenge: not done 
glc challenge: not done 
Interattack NE: normal 
Sptont [K+]: 4.4 
K challenge: weakness 
glc challenge: normal 
Interattack NE: myopathy 
Spont [K+]: not done 
K+ challenge: weakness 
glc challenge: normal 
Interattack NE: normal 
Sp:nt [K+]: not done 
K challenge: not done 
glc challenge: not done 
Interattack NE: normal 
Spont [K+]: not done 
Kt challenge: weakness 
glc challenge: not done 
Interattack NE: myopathy 
Ventricular tachycardia 
Ventricular tachycardia 
Ventricular tachycardia 
Bidirectional ventricular 
tachycardia 
Sinus arrhythmia” 
Ventricular tachycardia 
Bidirectional ventricular 
tachycardia 
Bidirectional ventricular 
tachycardia 
Bidirectional ventricular 
tachycardia 
Not mentioned 
Present 
Not mentioned 
Not mentioned 
Not mentioned 
Not mentioned 
Present 
Not mentioned 
Not mentioned 
“In this patient, a cardiomyopathy was also found. 
Spont [Kt] = serum potassium levels (in niEq/L) during a spontaneous attack of weakness; glc = glucose and insulin challenge; NE = 
neurologic examination. 
Modified from Rowland LP. Andersen’s syndrome? Or Hein-Lisak-Andersen syndrome? Ann Neurol 1994;35:252-253 (Letter). 
Case Reports 
PATIENT 1 (FAMILY 1,  111-1). A 15-year-old girl was referred 
for evaluation of recurrent episodic weakness and progressive 
proximal limb weakness. At 4 years of age, she had a nonfa- 
tal cardiac arrest. Bidirectional ventricular tachycardia was di- 
agnosed and she was treated with P-blockers. At age 10, she 
first noted limb weakness on waking, which resolved within 
2 hours. Examination revealed short stature (<3rd percentile 
for age), low-set ears, broad nose, clinadactyly of the fifth 
fingers, syndactyly of the second and third toes, scoliosis, and 
hypotrophy of the anterior and posterior compartments of 
the right leg. Mild psychomotor delay was evident. Shoulder 
and pelvic girdle weakness (grade 4, Medical Research Coun- 
cil [MRC]) and atrophy were seen, with Gowers’ sign, bilat- 
eral scapular winging, compensatory hyperlordosis, and genu 
recurvatum. There was no clinical myotonia, including lin- 
gual myotonia. Tendon reflexes were increased and plantar 
responses were upgoing. Sensation was normal. Brain and 
spinal cord magnetic resonance imaging were unremarkable. 
ECG showed a long QT interval (QT, = 0.47 msec). An 
oral glucose challenge test (1.5 glkg) resulted in weakness at 
KC levels of 2.7 mEqiL. Potassium levels during spontane- 
ous attacks of weakness ranged from 2.5 to 3.0 mEq/L. Po- 
tassium challenge was not performed because of the risk of 
precipitating fatal ventricular tachycardias. EMG of limb 
muscles showed no evidence of myotonia even after cooling. 
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Muscle biopsy was consistent with a mild chronic myopathy 
with tubular aggregates. 
PATIENT 2 (FAMILY 1, 111-2). The 8-year-old sister of Pa- 
tient l never experienced episodic weakness, although she 
had occasional bouts of palpitation. Examination showed a 
slender girl of short stature ((3rd percentile), mandibular 
hypoplasia, low-set ears, hypertelorism, clinodactyly of the 
fifth fingers of both hands, syndactyly of the second and 
third toes of her left foot (Fig D-F). Findings of neurologic 
examination were normal. ECG showed a long QT interval 
(QT, = 0.48 msec). 
PATIENT 3 (FAMILY 1, 11-2). A 45-year-old man, the father 
of Patients 1 and 2, had one syncopal episode at age 13. His 
ECG showed a prolonged QT interval (QT, = 0.47 msec), 
with runs of ventricular tachycardia. His only episode of 
muscular weakness occurred at age 18 years after prolonged 
exercise in military service. The episode resolved spontane- 
ously within 3 hours. Examination showed short stature, 
broad neck, broad nose, prognathism, clinodactyly of the 
second fingers of both hands, simple syndactyly of the sec- 
ond and third toes of his feet. Neurologic examination was 
normal except for decreased tendon reflexes. An oral glucose 
challenge (1.5 glkg) induced weakness at a potassium level of 
3.1 mEq/L (baseline, 4.5 mEq/L). There was no electrical 
myotonia on EMG and a muscle biopsy specimen showed a 
mild chronic myopathy with tubular aggregates. 
PATIENT 4 (FAMILY 1, 1-2). An 87-year-old woman, the pa- 
ternal grandmother of Patients l and 2, had no episodes of 
weakness. Examination revealed features similar to those in 
other affected family members, ie, low-set ears, mandibular 
hypoplasia, clinodactyly of the fifth fingers of both hands, 
and syndactyly between the second and third fingers of both 
feet. Neuromuscular examination was normal. ECG showed 
asymptomatic bidirectional ventricular tachycardia and a 
prolonged QT interval (QT, = 0.48 msec). 
PATIENT 5 .  A 16-year-old boy was referred for evaluation 
of episodic weakness. At age 7, a routine ECG showed 
asymptomatic ventricular tachycardia. H e  was treated with 
amiodarone, which was discontinued 10 months later when 
he developed profound symptomatic bradycardia and other 
amiodarone side effects. A pacemaker was inserted and he 
was given flecainide. He had no cardiac symptoms thereafter. 
At age 14, he had episodes of transient weakness about once 
every 5 weeks. During one attack, the serum potassium level 
was 2.7 mEqlL. The family history was negative for any car- 
diac or neurologic disorder. O n  examination, his height was 
normal for age. The following nondisfiguring distinctive fea- 
tures were evident: low-set ears, hypertelorism, micrognathia, 
bilaterally short index fingers that only come to the distal 
interphalangeal joint of his middle finger, mild clinodactyly 
of his fifth fingers, and hypoplastic and low-set thumbs with 
very smooth and flat palmar creases (Fig. G-I). Neurologic 
examination showed lid lag but no facial weakness and no 
grip or percussion myotonia, including lingual myotonia. 
There was mild wasting of pectoral and hand muscles. Bilat- 
eral scapular winging was seen with grade 4 MRC shoulder 
and pelvic girdle weakness. Grade 4 MRC weakness was 
noted in the hands. Tendon reflexes were normal. The ECG 
showed a combination of intrinsic and pacemaker-induced 
rhythms. The QT interval, off flecainide, was prolonged 
(QT, = 0.48 msec). Oral potassium (0.05 g/kg) did not in- 
duce weakness (5.1 mEq/L at 60 minutes). The serum po- 
tassium level during a spontaneous attack was 2.7 mEq/L. 
EMG and muscle biopsy were normal. Both parents were 
asymptomatic with normal ECGs. 
PATIENT 6 (FAMILY 2, 11-1). A 14-year-old girl had a 10- 
year history of episodic weakness occurring at rest after heavy 
exercise. The attacks lasted 3 to 5 days and were ameliorated 
by continued physical activity. Serum potassium levels were 
consistently normal during attacks. ECG showed ventricular 
dysrhythmias leading to diagnosis of LQT syndrome (QT, 
= 0.47 msec) and she was given P-blockers. Asymptomatic 
ventricular tachyarrhythmias persisted and she was given ve- 
rapamil, which was associated with worsening of limb mus- 
cles that improved when the drug was discontinued. Exam- 
ination revealed a slender girl, short and thin for age (25th 
percentile) with micrognathia, low-set ears, hypertelorism, 
and mild clinodactyly with long palms bilaterally. Neurologic 
examination showed mild facial weakness, grade 4 MRC 
shoulder and pelvic girdle weakness, and normal tendon re- 
flexes. An oral potassium challenge (0.05 glkg) failed to pro- 
duce weakness, but there was a suboptimal increase in serum 
Kt and she refused further tests. The serum potassium level 
during a spontaneous attack was 4.3 mEq/L. Needle EMG 
showed no myotonia; muscle biopsy showed tubular aggre- 
gates. 
PATIENT 7 (FAMILY 2, 1-1). A 39-year-old woman, the 
mother of Patient 6, had an isolated asymptomatic pro- 
longed QT interval (QT, = 0.48 msec). She had no episodes 
of weakness, and baseline potassium levels were normal. No 
distinctive features were found on examination. 
PATIENT 8 (FAMILY 3, IV-1). This boy began having epi- 
sodes of weakness at age 2, without apparent precipitating 
events. Cardiac dysrhythmia was noted on a routine pediatric 
examination at age 9, with isolated premature ventricular 
contractions and intermittent short runs of bidirectional ven- 
tricular tachycardia. Although asymptomatic, he was given 
flecainide, which prolonged the QT, interval (QT, = 0.46 
msec). O n  examination, at age 13, he showed low-set ears, 
hypertelorism, micrognathia, and clinodactyly of the fifth 
fingers of both his hands. There was grade 4 MRC proximal 
limb weakness. Tendon reflexes were reduced. Sensation was 
normal. Serum potassium values were normal to high be- 
tween and during spontaneous actacks of weakness (3.7-5.5 
mEq/L). There was no myotonia on EMG, and muscle bi- 
opsy showed tubular aggregates. 
PATIENT 9 (FAMILY 3, 111-1). A 35-year-old woman, the 
mother of Patient 8, had asymptomatic ventricular dysrhyth- 
mias, with ECG evidence of a prolonged QT interval (QT, 
= 0.52 msec). She never had episodes of muscle weakness. 
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Fig. Lefi row shows f ior i t  views o f  Patienilc I I ,  2, and 5, respectively. Note the common traits, especially broad nose and low-set 
ears. Center row shows side views o f  the same patients, showzng the recurrent small mandible in these patients. Right row shows the 
main skeletal dysrnorphisms in the hands of these same patients. Note the abnormally short index jnger  of Patient 5 (I). 
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Mild clinodactyly of the fifth fingers was found. Neurologic 
findings were normal. 
PAI’IENT 10 (FAMILY 3, 111-2). A 64-year-old man, the 
maternal grandfather of Patient 8, was found to have LQT 
syndrome (QT, = 0.6 msec). He had no cardiac symptoms 
or limb weakness. Mild clinodactyly of the fifth fingers was 
found, with normal neurologic examination. 
PATIENT 1 I .  A 27-year-old woman was first evaluated at 
age 4 for episodic weakness associated with cramps and last- 
ing 3 to 24 hours. Evaluation at age 8 showed normal to 
high serum potassium levels during attacks (4.7 mEq/L). A 
muscle biopsy was normal as were her serum creatine kinase 
(CK) levels. Hypokalemic challenge produced ventricular ec- 
topy but no weakness, and provocative Kt challenge to 7 
mEq/L abolished the ventricular arrhythmias but did not re- 
sult in muscle weakness. At age 10 she had a nonfatal cardiac 
arrest, and a diagnosis of LQT syndrome with torsade de 
pointes was made (QT, = 0.56 msec). Quinidine was started 
because of recurrent episodes of syncope, but it prolonged 
her QT interval further. Now, almost a year off quinidine, 
the patient has no further cardiac symptoms. Her physical 
examination revealed a slender woman with high-arched pal- 
ate, hypertelorism, bilateral ptosis, micrognathia, broad fore- 
head, as well as hyperlordosis and scoliosis (Fig A-C). Neu- 
rologic examination showed shoulder girdle atrophy with 
bilateral scapular winging associated with a 4- MRC grade 
proximal weakness in a “hip-girdle”-type distribution. Foot 
dorsiflexion was in the 4- range. Tendon reflexes were ab- 
sent. She experiences occasional palpitations and has had one 
near syncopal episode in the last 3 years. A recent Holter 
monitor revealed frequent premature ventricular contrac- 
tions, occasionally in groups, although she had no symptoms 
during the study. She continues to have two or three epi- 
sodes of weakness per month. The patient was adopted, so a 
clear family history could not be obtained. However, she was 
told that her mother had similar distinctive features and a 
maternal grandmother died of cardiac arrest at age 45. 
Genetic Analysis 
ANDERSEN’S PEDIGREES. Three families were available to 
test the hypothesis that AS might be allelic with LQT syn- 
drome. The kindreds were of insufficient size to demonstrate 
linkage with significant lod scores. However, given informa- 
tive haplotypes, absence of linkage to a given locus can be 
demonstrated. 
DNA ISOLATION AND MARKER ANALYSIS. High-molec- 
ular-weight genomic DNA was isolated from whole blood 
lisate with a phenollchloroform extraction followed by iso- 
propanol precipitation. Genetic evaluation was undertaken in 
kindreds 1784, 3387, and 3442, using markers that are 
tightly linked to LQT loci. The markers genotyped in these 
families are shown in Table 2. End-labeled primers were pre- 
pared as follows: 25 pinol of primer, 50 mM Tris-HC1, 10 
mM MgCI,, 5.0 dithiothreitol, 8.4 U of T, polynucleotide 
kinase, and 6.0 ~1 of [y-32P]ATI’ (5 mol/ml, in a total vol- 
ume of 10 pl). This mixture was incubated at 37°C for 1 
hour and was then heated to 94°C for 3 minutes to inacti- 
vate the T4  polynucleotide kinase. 
The polymerase chain reaction (PCR) was used to amplify 
total genomic DNA, using primers flanking polymorphic re- 
gions. The reaction mixture contained 50 ng of genomic 
DNA, 10 pmol of each primer, 1 pmol of the end-labeled 
primer, 2.5 nmol of each deoxynucleoside rriphosphate, 10 
mM Tris-HCI (pH 8.4), 50 mM KCI, 1.5 MgC1, 1.0 Taq 
DNA polymerase (Promega) in a volume of 25 PI. I’CR was 
performed under the following conditions: (1) one cycle at 
94°C for 3 minutes, (2) 30 cycles, each at 72°C for 45 sec- 
onds, and (3) cooling to 4°C. After PCR, 10 ~1 of stop dye 
(98% formamide, 0.05% bromphenol blue, 0.05% xylene 
cyanol, and 20 mM EDTA) was added. Four microliters of 
each sample was then loaded on a 6Yo acrylaniide gel that 
contained 5.6 M urea, 32% formamide, 90 mM Tris-borate, 
p H  7.5, and 2 mM EDTA. Preelectrophoresis of gels was at 
a constant power (80 W/gel) with 90 mM Tris-borate (pH 
7.5) and 2 mM EDTA running buffer. Gels were placed on 
filter paper and exposed to x-ray film overnight at -20°C. 
Autoradiograms were analyzed for genotypes of the polymor- 
phic alleles. The results of the DNA analysis on the recom- 
binants to LQT loci are summarized in Table 2. 
Discussion 
I n  our  initial study of AS, we defined a clinical triad to 
distinguish AS from other forms of periodic paralysis. 
T h e  present study confirmed the validity o f  the triad, 
emphasizing intrafamilial phenotypic variability and es- 
tablishing LQT as the  most consistent cardiac maiiifeh- 
tation. However, contrary to our  initial report, the as- 
sociated periodic paralysis can be hyper-, hypo-, o r  
normokalemic [23]. 
In our  initial report, 3 of 4 patients were normokale- 
mic and I of 4 was hyperkalemic during spontaneous 
attacks. In all, attacks were induced by oral potassium 
challenge. They  were therefore described as having 
potassium-sensitive periodic paralysis, implying a 
Table 2. Recombinants to LQT Loci 
_____ ~ 
Kindred 
1784 3387 3442 
_ _ _ _ _ _ ~ . _ _ _  
LQTl  (KVLQT1) 
TH N # # 
Dl  IS1318 # # 0 
D7S505 # # 0 
D7S483 0 0 # 
D7S636 0 # # 
D3S 1 100 # # 
D3S1298 
D4S 193 0 0 # 
LQTZ (HERG) 
LQT3 (SCN5A) 
LQT4 (unk gene) 
______________ __- - 
LQT = long QT; (#) = marker was uninfortndtive in thew fami- 
lies; 0 = obligate recombinant; N = previously reporred nonobli- 
gate recombinant. 
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pathogenic similarity with hyperkalemic periodic paral- 
ysis [ 131. However, of the 5 index cases presented here, 
2 were unequivocally hypokalemic during spontaneous 
attacks of weakness, and the remaining 3 were normo- 
to mildly hyperkalemic. Potassium challenge was not 
performed in most patients because of the danger of 
worsening the cardiac arrhythmias. Potassium levels 
during spontaneous attacks were determined in each 
case. Although in most classical forms of periodic pa- 
ralysis, changes in serum potassium are consistently 
unidirectional during attacks, “normokalemic” or bi- 
phasic attacks, occurring with either hypo- or hy- 
perkalemic challenges have been reported in families 
with otherwise typical hyperkalemic periodic paralysis 
[24-261. We therefore conclude that, like other peri- 
odic paralysis, serum potassium shifts are inconsistent 
in the periodic paralysis of AS and that the traditional 
classification of hyper- or hypokalemic periodic paral- 
ysis cannot be applied. That shifts in serum potassium 
levels in Andersen’s periodic paralysis are unconven- 
tional is underscored by the absence of mutations in 
either the sodium channel or the calcium channel 
genes responsible for typical hyperkalemic [ 14-16] and 
hypokalemic [ 131 periodic paralysis. 
In retrospect, evaluation of changes in serum potas- 
sium in AS should be done only during spontaneous 
attacks of weakness. Provocative challenges, especially 
hypokalemic challenges, should not be undertaken in 
AS patients because hypokalemia may exacebate preex- 
isting QT prolongation and potentially cause life- 
threatening ventricular arrhythmias. 
The constancy and distinctness of the physical fea- 
Table 3. Szmmusy o f  Clinical Data 
tures in the cases presented demonstrate that they rep- 
resent an integral part of this syndrome. Although 
these features were clearly present in all our index cases 
(see Fig), there was substantial variability in the clinical 
expression within each family (Tables 3 and 4) .  
The cardiac disorder of AS varies from asymptom- 
atic LQT to potentially fatal ventricular tachyarrhyth- 
mias. The QT interval was prolonged in 12 of 15 of 
reported cases [13], some antedating the onset of epi- 
sodic weakness. In 2 kindreds described here, grand- 
parents of the index cases had isolated asymptomatic 
LQT. This observation suggests a clinical overlap be- 
tween typical LQT and AS. It is noteworthy that LQT 
patients may show syndactyly without periodic paraly- 
sis [27, 281. Although the phenotypic variability in our 
kindreds might suggest anticipation, ascertainment bias 
or random variability in disease expression cannot be 
excluded, given the small number of cases. 
Linkage analysis had previously excluded linkage of 
AS to the HyperKPP locus on chromosome 17 as well 
as to the LQTl locus on chromosome 1 1 [13]. Link- 
age studies in the present kindreds confirm these ob- 
servations. In addition, mutation analysis excluded 
common HypoKPP mutations in the dihydropyridine 
receptor gene [ 191. 
Because cardiac and skeletal muscle contain different 
isoforms of the major ion channel proteins, the coex- 
istence of abnormalities of cardiac and skeletal muscle 
membrane excitability in AS suggests that the patho- 
genic mechanism must alter the function of more than 
one specific channel. This could be achieved by a de- 
fective regulatory protein common to both tissues [29].  
Patient 
~ ~~ .- 
1 2 3 4 5 6 7 8  9 10 11 12” 13“ 14” 15“ 
Onset of muscle 
symptoms (yr) 
Onset of cardiac 
symptoms (yr) 
Spont [ K ’  1 
(mEqiL) 
Interattack weakness 
M yo to n i a 
CK (IU) 
Muscle biopsy 
QT‘ (msec) 
B V T  
Cardiac arrest 
Dysmorphisms 
Heredity 
10 
6 
2.5 
+ 
1-2x 
TA 
0.47 
+ 
+ 
+ 
AD 
- 
- 
- 
N D  
- 
- 
1-2x 
ND 
0.48 
+ 
+ 
AU 
- 
18 
13 
N D 
- 
- 
N 
’TA 
0.47 
+ 
+ 
AD 
- 
- 14 
- 7  
ND 2.7 
- +  
N N  
ND N 
0.48 0.48 
- +  
+ +  
AD S? 
- - 
- - 
4 
- 
4.3 
+ 
N 
TA 
0.47 
+ 
+ 
AD 
- 
- 
- 2 
4.1 ND ND 
+ -  
1-2X N N 
TA N D  ND 
0.46 0.52 0.60 
+ + -  
+ + +  
AD AD A D  
- - - 
- - - 
4 
10 
4.7 
+ 
N 
TA 
0.47 
+ 
+ 
AD? 
- 
- 
10 
- 
N D 
+ 
1-5X 
TA 
0.48 
+ 
- 
- 
+ 
AD 
15 
- 
ND 
+ 
1-2x 
ND 
0.43 
+ 
+ 
AD 
- 
- 
13 
- 
ND 
+ 
N 
TA 
0.46 
+ 
+ 
S? 
- 
- 
18 
- 
5.2 
+ 
1-2x 
TA 
0.56 
- 
- 
- 
+ 
S? 
“Patients from our  previous report [13]. 
Spoilt [K ‘1 = serum potassium levels (in mEq/L) during a spontaneous attack of weakness; CK = creatine kinase; (+) = present; (-) 
= absent; N = normal; ND = not done; TA = tubular aggregates; BVT = bidirectional ventricular tachycardia; AD = autosomal 
dominant; S = sporadic. 
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Table 4. Muin Dysmorphic Features in AS 
Facial and Skeletal 
Abnormalities No. of Patients 
Face 
Eyes: hypertelorism 
Ears: low set 
Nose: broad 
Mandible: small 
Clinodactyly 
Abnormal digit length 
Abnormal palm length 
S yndactyly 
High arched 
Scaphoencephalic 
Scoliosis 
Hands 
Feet 
Palate 
Skull 
Vertebral column 
5 and 3" 
7 and 2" 
2 and 2" 
7 and 3" 
7 and 4" 
1 
2 
3 
2 
1 
3 and I"  
"Patients from our previous report [ 131. 
AS = Andersen's syndrome. 
In contrast, the genetic lesion could involve more than 
one gene. Multiple channel abnormalities have been 
documented by patch-clamp techniques in Schwartz- 
Jampel syndrome, a disorder similar to AS in combin- 
ing abnormal skeletal muscle membrane excitability 
with distinctive skeletal features [30, 311. The gene le- 
sion(s) responsible for AS must also explain the charac- 
teristic physical findings. This complex phenotype also 
suggests a genetic disorder of multiple genes. How- 
ever, Holt-Oram syndrome, the prototypical heart- 
hand disorder, is the result of a single gene mutation 
132, 331. 
Genetic heterogeneity in periodic paralysis with car- 
diac arrhythmia is likely. Before our 1994 report, other 
patients with periodic paralysis and cardiac arrhythmias 
had been described (see Table I )  [ I ,  4-12]. Only 2 
were noted to have distinctive physical features [4, 101 
and none had a prolonged QT,  although it is unclear 
whether these features were specifically looked for. 
However, with the recent description of a case of pe- 
riodic paralysis with cardiac arrhythmias associated 
with a sodium channel mutation [12], it appears pos- 
sible that there exist syndromes of periodic paralysis 
with cardiac involvement distinct from AS, although 
the gene defect has still to be identified. 
Our data indicate that AS is a unique autosomal 
dominant disorder with distinctive clinical features and 
that it is genetically distinct from the common forms 
of periodic paralysis and LQT syndromes. The full 
clinical triad includes (1) hypo-, normo-, or hyperkale- 
mic periodic paralysis, (2) prolonged QT interval in 
80% of cases and ventricular arrhythmias, and (3) dis- 
tinctive physical features. However, partial manifesta- 
tions of the syndrome are common in family members 
of patients with the full AS triad, often with a pro- 
longed QT interval as the minimal manifestation. Rec- 
ognition of this potentially life-threatening disorder is 
essential in the diagnostic workup of all patients with 
suspected periodic paralysis. QT, intervals should be 
measured and, if prolonged, diagnostic hypokalemic 
and hyperkalemic challenges should be avoided, in fa- 
vor of graded exercise protocols designed to precipitate 
attacks of paralysis. In a similar manner, AS should be 
considered in the differential diagnosis of LQT syn- 
dromes, especially in the presence of distinctive physi- 
cal features. 
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